BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15279664)

  • 21. Haematological Effects of Intermittent Pneumatic Compression for Deep Vein Thrombosis Prophylaxis.
    Morris RJ; Roberts CH
    Thromb Haemost; 2020 Jun; 120(6):912-923. PubMed ID: 32359225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between seated immobility and local lower-limb venous coagulability in healthy adult volunteers: a simulation of prolonged travel immobility.
    Ansari MT; Mahmood MT; Karlberg JP
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):335-41. PubMed ID: 16788308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of deep vein thrombosis in spite of using an intermittent pneumatic compression device].
    Matsuda T; Inoue S; Sakamoto T; Uji M; Nagai A; Shinjo T; Hirai K; Furuya H
    Masui; 2005 Jul; 54(7):805-8. PubMed ID: 16026068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The urokinase system in patients with intermittent and persistent allergic rhinitis.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):685-8. PubMed ID: 18832910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanical compression in the prophylaxis of venous thromboembolism.
    MacLellan DG; Fletcher JP
    ANZ J Surg; 2007 Jun; 77(6):418-23. PubMed ID: 17501878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic and fibrinolytic consequences of intermittent pneumatic compression: preliminary results.
    Jacobs DG; Piotrowski JJ; Hoppensteadt DA; Salvator AE; Fareed J
    J Trauma; 1996 May; 40(5):710-16; discussion 716-7. PubMed ID: 8614068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal levels of urokinase plasminogen activator protein and tissue plasminogen activator activity in human aortic aneurysms.
    Falkenberg M; Holmdahl L; Tjärnström J; Risberg B
    Eur J Surg; 2001 Jan; 167(1):10-4. PubMed ID: 11213813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2008; 121(6):787-91. PubMed ID: 17869326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
    Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
    Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemostatic factors in women with history of preeclampsia.
    Portelinha A; Cerdeira AS; Belo L; Braga J; Tejera E; Pinto A; Pinto F; Areias MJ; Patrício B; Rebelo I
    Thromb Res; 2009 May; 124(1):52-6. PubMed ID: 19049844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemostatic parameters in patients with primitive venous hypertension.
    Trifiletti A; Scamardi R; Pizzoleo MA; Nevoso A; Attina A; Soraci S; Bagnato L; Barbera N
    Panminerva Med; 1997 Jun; 39(2):100-2. PubMed ID: 9230618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
    Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
    Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritoneal fibrinolytic response to various aspects of laparoscopic surgery: a randomized trial.
    Brokelman WJ; Holmdahl L; Bergström M; Falk P; Klinkenbijl JH; Reijnen MM
    J Surg Res; 2006 Dec; 136(2):309-13. PubMed ID: 17054995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemostatic changes in patients with deep vein thrombosis.
    Trifiletti A; Scamardi R; Pizzoleo MA; Soraci S; Nevoso A; Bagnato L; Barbera N
    Panminerva Med; 1997 Mar; 39(1):21-3. PubMed ID: 9175416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of tissue factor pathway during intermittent pneumatic compression: A possible mechanism for antithrombotic effect.
    Chouhan VD; Comerota AJ; Sun L; Harada R; Gaughan JP; Rao AK
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2812-7. PubMed ID: 10559031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High concentrations of plasminogen activator inhibitor-1 in lungs of preterm infants with respiratory distress syndrome.
    Cederqvist K; Sirén V; Petäjä J; Vaheri A; Haglund C; Andersson S
    Pediatrics; 2006 Apr; 117(4):1226-34. PubMed ID: 16585319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinolysis after application of a pneumatic tourniquet.
    Petäjä J; Myllynen P; Myllylä G; Vahtera E
    Acta Chir Scand; 1987; 153(11-12):647-51. PubMed ID: 3124428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes in fibrinolysis-associated parameters in HELLP syndrome].
    Kolben M; Lopens A; Schmitt M; Schneider KT; Graeff H
    Geburtshilfe Frauenheilkd; 1994 May; 54(5):257-61. PubMed ID: 8050684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour-associated urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in normal and neoplastic tissues of patients with squamous cell cancer of the oral cavity - clinical relevance and prognostic value.
    Hundsdorfer B; Zeilhofer HF; Bock KP; Dettmar P; Schmitt M; Kolk A; Pautke C; Horch HH
    J Craniomaxillofac Surg; 2005 Jun; 33(3):191-6. PubMed ID: 15878520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.